1. Home
  2. ASTI vs PCSA Comparison

ASTI vs PCSA Comparison

Compare ASTI & PCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTI
  • PCSA
  • Stock Information
  • Founded
  • ASTI 2005
  • PCSA 2011
  • Country
  • ASTI United States
  • PCSA United States
  • Employees
  • ASTI N/A
  • PCSA N/A
  • Industry
  • ASTI Semiconductors
  • PCSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTI Technology
  • PCSA Health Care
  • Exchange
  • ASTI Nasdaq
  • PCSA Nasdaq
  • Market Cap
  • ASTI 3.1M
  • PCSA 2.8M
  • IPO Year
  • ASTI N/A
  • PCSA N/A
  • Fundamental
  • Price
  • ASTI $1.25
  • PCSA $0.31
  • Analyst Decision
  • ASTI
  • PCSA Strong Buy
  • Analyst Count
  • ASTI 0
  • PCSA 1
  • Target Price
  • ASTI N/A
  • PCSA $6.00
  • AVG Volume (30 Days)
  • ASTI 133.2K
  • PCSA 2.8M
  • Earning Date
  • ASTI 05-08-2025
  • PCSA 05-09-2025
  • Dividend Yield
  • ASTI N/A
  • PCSA N/A
  • EPS Growth
  • ASTI N/A
  • PCSA N/A
  • EPS
  • ASTI N/A
  • PCSA N/A
  • Revenue
  • ASTI $41,893.00
  • PCSA N/A
  • Revenue This Year
  • ASTI N/A
  • PCSA N/A
  • Revenue Next Year
  • ASTI N/A
  • PCSA N/A
  • P/E Ratio
  • ASTI N/A
  • PCSA N/A
  • Revenue Growth
  • ASTI N/A
  • PCSA N/A
  • 52 Week Low
  • ASTI $1.20
  • PCSA $0.24
  • 52 Week High
  • ASTI $35.80
  • PCSA $3.31
  • Technical
  • Relative Strength Index (RSI)
  • ASTI 28.40
  • PCSA 26.91
  • Support Level
  • ASTI $1.20
  • PCSA $0.24
  • Resistance Level
  • ASTI $1.90
  • PCSA $0.49
  • Average True Range (ATR)
  • ASTI 0.15
  • PCSA 0.06
  • MACD
  • ASTI -0.04
  • PCSA -0.00
  • Stochastic Oscillator
  • ASTI 6.67
  • PCSA 29.23

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its "regulatory science" approach in the development of Next Generation Chemotherapy ("NGC") oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small molecule oncology drugs. The NGC products are new chemical entities, but the company work by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are - NGC-Capecitabine (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

Share on Social Networks: